Subscribe to RSS
Prevalence of Anti-HBc Antibodies among HBsAg Negative Individuals and Its Association with Occult Hepatitis BFinancial Support Nil.
Introduction Hepatitis B virus (HBV) infection is an endemic in many Asian countries, and among the major routes of transmission, transfusion is the one that should be prevented. Occult HBV infection (OBI) is defined as the presence of HBV DNA in the absence of detectable HBsAg, with or without anti-HBV antibodies. The aim of this study was to detect the prevalence of anti-HBc total antibodies among the HB surface antigen (HBsAg) negative individuals by way of enzyme-linked immunosorbent assay (ELISA), and detect the presence of HBV DNA among the anti-HBc seropositives by polymerase chain reaction (PCR). Anti-HBs among the HBV DNA positives were also found out by enzyme-linked fluorescent assay (ELFA).
Materials and Methods A total of 910 serum samples was subjected to initial screening for HBsAg by MERILISA HBsAg ELISA kits. The anti-HB core (HBc) total antibody titer was evaluated using MONOLISA ELISA (Biorad) kits. If found negative, the samples were discarded. If found positive, the samples underwent HBV DNA testing by nested PCR. Antibody to hepatitis B surface antigen (anti-HBs) was calculated among the DNA positives by ELFA.
Results A total of 133 samples were positive for anti-HBC total antibody, resulting in an overall prevalence of 14.6%. Overall prevalence of HBV DNA among the anti-HBc seropositives was 2.2%.
Conclusion Among the three HBV DNA positive patients, two belonged to the preoperative screening group, which is an alarming situation. Screening of blood for HBsAg has reduced the incidence of posttransfusion hepatitis, but HBV still remains the major source of transfusion transmitted infection in India.
19 May 2021 (online)
© 2021. The Indian Association of Laboratory Physicians. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).
Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India
- 1 Ray G. Current Scenario of Hepatitis B and Its Treatment in India. J Clin Transl Hepatol 2017; 5 (03) 277-296
- 2 Busch MP. Should HBV DNA NAT replace HBsAg and/or anti-HBc screening of blood donors?. Transfus Clin Biol 2004; 11 (01) 26-32
- 3 Allain JP. Occult hepatitis B virus infection. Hep B Annual 2005; 2: 14-30
- 4 Said ZN. An overview of occult hepatitis B virus infection. World J Gastroenterol 2011; 17 (15) 1927-1938
- 5 Raimondo G, Allain JP, Brunetto MR. et al. Statements from the Taormina expert meeting on occult hepatitis B virus infection. J Hepatol 2008; 49 (04) 652-657
- 6 Panhotra BR, Bahrani A, Joshi CS, ul Hassan Z. Occult hepatitis B virus infection among anti-HBc positive blood donors: Necessitates substitution of screening by HBV NAT. J Infect 2005; 51 (03) 263
- 7 Prati D, Gerosa A, Porretti L. Occult HBV infection and blood transfusion. J Hepatol 2006; 44 (04) 818-, author reply 819
- 8 Giudice CL, Martinengo M, Pietrasanta P. et al. Occult hepatitis B virus infection: a case of reactivation in a patient receiving immunosuppressive treatment for allogeneic bone marrow transplantation. Blood Transfus 2008; 6 (01) 46-50
- 9 Shi Y, Wu YH, Wu W, Zhang WJ, Yang J, Chen Z. Association between occult hepatitis B infection and the risk of hepatocellular carcinoma: a meta-analysis. Liver Int 2012; 32 (02) 231-240
- 10 Chattopadhyay S, Rao S, Das BC, Singh NP, Kar P. Prevalence of transfusion-transmitted virus infection in patients on maintenance hemodialysis from New Delhi, India. Hemodial Int 2005; 9 (04) 362-366
- 11 Vyas GN. Algorithm for safe blood with regard to transfusion acquired infections. In: Sarin SK, Hess G, eds. Transfusion Associated Hepatitis. Diagnosis, Treatment and Prevention. New Delhi: CBS Publishers & Distributors 1998: 462-478
- 12 Dreier J, Kröger M, Diekmann J, Götting C, Kleesiek K. Low-level viraemia of hepatitis B virus in an anti-HBc- and anti-HBs-positive blood donor. Transfus Med 2004; 14 (02) 97-103
- 13 Dickson RC, Everhart JE, Lake JR. et al. The National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database. Transmission of hepatitis B by transplantation of livers from donors positive for antibody to hepatitis B core antigen. Gastroenterology 1997; 113 (05) 1668-1674
- 14 Allain J-P, Mihaljevic I, Gonzalez-Fraile MI. et al. Infectivity of blood products from donors with occult hepatitis B virus infection. Transfusion 2013; 53 (07) 1405-1415
- 15 Hollinger FB. Hepatitis B virus infection and transfusion medicine: science and the occult. Transfusion 2008; 48 (05) 1001-1026
- 16 Asim M, Ali R, Khan LA, Husain SA, Singla R, Kar P. Significance of anti-HBc screening of blood donors and its association with occult hepatitis B virus infection: Implications for blood transfusion. Indian J Med Res 2010; 132: 312-317
- 17 Chaudhuri V, Nanu A, Panda SK, Chand P. Evaluation of serologic screening of blood donors in India reveals a lack of correlation between anti-HBc titer and PCR-amplified HBV DNA. Transfusion 2003; 43 (10) 1442-1448
- 18 Bhattacharya P, Chandra PK, Datta S. et al. Significant increase in HBV, HCV, HIV and syphilis infections among blood donors in West Bengal, Eastern India 2004-2005: exploratory screening reveals high frequency of occult HBV infection. World J Gastroenterol 2007; 13 (27) 3730-3733
- 19 Makroo RN, Chowdhry M, Bhatia A, Arora B, Rosamma NL. Hepatitis B core antibody testing in Indian blood donors: A double-edged sword!. Asian J Transfus Sci 2012; 6 (01) 10-13
- 20 Ismail AM, Devakumar S, Anantharam R. et al. Low frequency of occult hepatitis B infection in anti-HBc seropositive blood donors: experience from a tertiary care centre in South India. Blood Transfus 2012; 10 (02) 230-232
- 21 Keechilot CS, Shenoy V, Kumar A. et al. Detection of occult hepatitis B and window period infection among blood donors by individual donation nucleic acid testing in a tertiary care center in South India. Pathog Glob Health 2016; 110 (07/08) 287-291
- 22 Saha D, Pal A, Sarkar N. et al. Occult hepatitis B virus infection in HIV positive patients at a tertiary healthcare unit in eastern India. PLoS One 2017; 12 (06) e0179035
- 23 Gupta S, Singh S. Occult hepatitis B virus infection in ART-naive HIV-infected patients seen at a tertiary care centre in north India. BMC Infect Dis 2010; 10: 53
- 24 Núñez M, Ríos P, Pérez-Olmeda M, Soriano V. Lack of ‘occult’ hepatitis B virus infection in HIV-infected patients. AIDS 2002; 16 (15) 2099-2101
- 25 Cohen Stuart JW, Velema M, Schuurman R, Boucher CA, Hoepelman AI. Occult hepatitis B in persons infected with HIV is associated with low CD4 counts and resolves during antiretroviral therapy. J Med Virol 2009; 81 (03) 441-445
- 26 Yakaryilmaz F, Gurbuz OA, Guliter S. et al. Prevalence of occult hepatitis B and hepatitis C virus infections in Turkish hemodialysis patients. Ren Fail 2006; 28 (08) 729-735
- 27 Aghakhani A, Banifazl M, Kalantar E. et al. Occult hepatitis B virus infection in hemodialysis patients with isolated hepatitis B core antibody: a multicenter study. Ther Apher Dial 2010; 14 (03) 349-353
- 28 Fabrizi F, Messa PG, Lunghi G. et al. Occult hepatitis B virus infection in dialysis patients: a multicentre survey. Aliment Pharmacol Ther 2005; 21 (11) 1341-1347
- 29 Kalantari H, Ferdowsi F, Yaran M. Prevalence of occult hepatitis B virus infection in hemodialysis patients in Isfahan, Iran. Adv Biomed Res 2016; 5: 151
- 30 Sood AK, Pangotra C, Manrai M. Prevalence of occult hepatitis B infection in patients visiting tertiary care hospital. Med J Armed Forces India 2016; 72 (02) 140-144
- 31 Cacciola I, Pollicino T, Squadrito G, Cerenzia G, Orlando ME, Raimondo G. Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease. N Engl J Med 1999; 341 (01) 22-26
- 32 Hashemi SJ, Hajiani E, Masjedizadeh A. et al. Occult hepatitis B infection in patients with cryptogenic liver cirrhosis in southwest of iran. Jundishapur J Microbiol 2015; 8 (03) e16873